Status:
COMPLETED
Effect of Intrathecal Naloxone in the Incidence of Pruritis After C.S
Lead Sponsor:
Tanta University
Conditions:
Pruritis
Eligibility:
FEMALE
21-30 years
Phase:
NA
Brief Summary
This randomized prospective double-blind trial will be conducted on 80 Full-term pregnant females aged 21- 30 years presented for elective cesarean section under spinal anesthesia where they will be r...
Detailed Description
This prospective randomized double-blind study will be carried out on 80 female patients who will be presented for elective C.S in the Obstetric department in Tanta university hospitals. Full-term pr...
Eligibility Criteria
Inclusion
- Full-term pregnant female aged 21- 30 years presented for elective cesarean section under spinal anesthesia.
Exclusion
- Patients with pregnancy less than 36 weeks or more than 40 weeks
- Patients with hypertension, pre-eclampsia, or eclampsia.
- Patients with diabetes
- Patients with cardiovascular disease and /or arrhythmia.
- Patients with placenta previa, accreta, percreta.
- Obese patients with BMI \>36 Kg/m2
- Patients with height less than 160 Cm
- Multigravida
- Polyhydramnious patients
Key Trial Info
Start Date :
September 11 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 7 2021
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT04518618
Start Date
September 11 2020
End Date
March 7 2021
Last Update
March 26 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine
Tanta, Algharbia, Egypt, 31511
2
Tanta University hospitals
Tanta, Egypt, 31511